Body mass index moderates the relationship between the apnea‐hypopnea index and CSF biomarker of activated microglia

IF 13 1区 医学 Q1 CLINICAL NEUROLOGY
Julia Bink, Yue Ma, Bryce A Mander, David T Plante, Margherita Carboni, Norbert Wild, Nathaniel A. Chin, Ozioma C Okonkwo, Cynthia M. Carlsson, Carey E. Gleason, Sanjay Asthana, Sterling C. Johnson, Kaj Blennow, Henrik Zetterberg, Ruth M Benca, Barbara B. Bendlin
{"title":"Body mass index moderates the relationship between the apnea‐hypopnea index and CSF biomarker of activated microglia","authors":"Julia Bink, Yue Ma, Bryce A Mander, David T Plante, Margherita Carboni, Norbert Wild, Nathaniel A. Chin, Ozioma C Okonkwo, Cynthia M. Carlsson, Carey E. Gleason, Sanjay Asthana, Sterling C. Johnson, Kaj Blennow, Henrik Zetterberg, Ruth M Benca, Barbara B. Bendlin","doi":"10.1002/alz.095742","DOIUrl":null,"url":null,"abstract":"BackgroundPrior studies suggest that obstructive sleep apnea (OSA) may be associated with Alzheimer’s disease (AD) pathology, including Aβ42/Aβ40 and p‐Tau181. However, less is known about relationships between OSA and non‐AD pathology, including neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), S100, chitinase 3‐like 1 (YKL40), and soluble triggering receptor expressed on myeloid cells 2 (sTREM2), as well as the effect of potential moderating factors. The present study investigated the relationship between the apnea‐hypopnea index (AHI) and cerebrospinal fluid (CSF) biomarkers of AD and related pathology.MethodIn this cross‐sectional study, 73 cognitively unimpaired adults with no prior OSA diagnosis underwent an overnight PSG and/or testing with an at home ApneaLink. Participants completed a lumbar puncture to determine Aβ42/Aβ40, pTau181, NfL, GFAP, s100, YKL‐40, and sTREM2 as part of the Roche NeuroToolKit research platform (Roche International). Relationships between AHI and CSF biomarkers were tested using multiple linear regression adjusting for age, sex, <jats:italic>APOE</jats:italic> genotype, and BMI. Given prior studies suggesting potential interaction effects, we also examined interactions between AHI and <jats:italic>APOE</jats:italic> and interactions between AHI and BMI.ResultAHI determined using PSG and at home Apnealink were highly correlated (r = 0.78, p &lt; 0.01). There were no significant main effects of AHI on any of the CSF biomarkers, controlling for covariates (p &gt; 0.05). Further, there was no significant interaction between <jats:italic>APOE</jats:italic> and AHI (p &gt; 0.05). We found a significant interaction between BMI and AHI, such that participants with lower BMI showed higher sTREM2 with greater AHI, (p = 0.02; Figure 1). However, this positive relationship diminished with higher BMI.ConclusionOSA and obesity are intrinsically linked processes, however prior studies in sleep have also shown that these factors have interactive effects on several outcomes, including measures of inflammation and cognitive function. Here, we found that individuals who had lower BMI showed a potentially deleterious effect of AHI on measures of microglial activation. Additional studies are needed to determine whether these results are due to possible protective effects of higher BMI, or differences in sleep quality among individuals with high and low BMI.","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"24 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.095742","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundPrior studies suggest that obstructive sleep apnea (OSA) may be associated with Alzheimer’s disease (AD) pathology, including Aβ42/Aβ40 and p‐Tau181. However, less is known about relationships between OSA and non‐AD pathology, including neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), S100, chitinase 3‐like 1 (YKL40), and soluble triggering receptor expressed on myeloid cells 2 (sTREM2), as well as the effect of potential moderating factors. The present study investigated the relationship between the apnea‐hypopnea index (AHI) and cerebrospinal fluid (CSF) biomarkers of AD and related pathology.MethodIn this cross‐sectional study, 73 cognitively unimpaired adults with no prior OSA diagnosis underwent an overnight PSG and/or testing with an at home ApneaLink. Participants completed a lumbar puncture to determine Aβ42/Aβ40, pTau181, NfL, GFAP, s100, YKL‐40, and sTREM2 as part of the Roche NeuroToolKit research platform (Roche International). Relationships between AHI and CSF biomarkers were tested using multiple linear regression adjusting for age, sex, APOE genotype, and BMI. Given prior studies suggesting potential interaction effects, we also examined interactions between AHI and APOE and interactions between AHI and BMI.ResultAHI determined using PSG and at home Apnealink were highly correlated (r = 0.78, p < 0.01). There were no significant main effects of AHI on any of the CSF biomarkers, controlling for covariates (p > 0.05). Further, there was no significant interaction between APOE and AHI (p > 0.05). We found a significant interaction between BMI and AHI, such that participants with lower BMI showed higher sTREM2 with greater AHI, (p = 0.02; Figure 1). However, this positive relationship diminished with higher BMI.ConclusionOSA and obesity are intrinsically linked processes, however prior studies in sleep have also shown that these factors have interactive effects on several outcomes, including measures of inflammation and cognitive function. Here, we found that individuals who had lower BMI showed a potentially deleterious effect of AHI on measures of microglial activation. Additional studies are needed to determine whether these results are due to possible protective effects of higher BMI, or differences in sleep quality among individuals with high and low BMI.
求助全文
约1分钟内获得全文 求助全文
来源期刊
Alzheimer's & Dementia
Alzheimer's & Dementia 医学-临床神经学
CiteScore
14.50
自引率
5.00%
发文量
299
审稿时长
3 months
期刊介绍: Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信